Search Results - "Alcaraz, Lindsay"
-
1
Latent TGF-β Activation Is a Hallmark of the Tenascin Family
Published in Frontiers in immunology (13-05-2021)“…Transforming growth factor-β (TGF-β) isoforms are secreted as inactive complexes formed through non-covalent interactions between bioactive TGF-β entities and…”
Get full text
Journal Article -
2
Trpv6 channel targeting using monoclonal antibody induces prostate cancer cell apoptosis and tumor regression
Published in Cell death & disease (15-06-2024)“…TRPV6 calcium channel is a prospective target in prostate cancer (PCa) since it is not expressed in healthy prostate while its expression increases during…”
Get full text
Journal Article -
3
A 9-kDa matricellular SPARC fragment released by cathepsin D exhibits pro-tumor activity in the triple-negative breast cancer microenvironment
Published in Theranostics (01-01-2021)“…Alternative therapeutic strategies based on tumor-specific molecular targets are urgently needed for triple-negative breast cancer (TNBC). The protease…”
Get full text
Journal Article -
4
Anti-cathepsin D immunotherapy triggers both innate and adaptive anti-tumour immunity in breast cancer
Published in British journal of pharmacology (26-01-2024)“…Triple-negative breast cancer (TNBC) has poorer outcomes than other breast cancers (BC), including HER2 BC. Cathepsin D (CathD) is a poor prognosis marker…”
Get full text
Journal Article -
5
Tenascin-X promotes epithelial-to-mesenchymal transition by activating latent TGF-β
Published in The Journal of cell biology (12-05-2014)“…Transforming growth factor β (TGF-β) isoforms are secreted as inactive complexes formed through noncovalent interactions between the bioactive TGF-β entity and…”
Get full text
Journal Article -
6
SPARC in cancer‐associated fibroblasts is an independent poor prognostic factor in non‐metastatic triple‐negative breast cancer and exhibits pro‐tumor activity
Published in International journal of cancer (15-03-2023)“…Triple‐negative breast cancer (TNBC) is the most aggressive breast cancer subtype and lacks specific targeted therapeutic agents. The current mechanistic…”
Get full text
Journal Article -
7
TIF1γ Suppresses Tumor Progression by Regulating Mitotic Checkpoints and Chromosomal Stability
Published in Cancer research (Chicago, Ill.) (15-10-2015)“…The transcription accessory factor TIF1γ/TRIM33/RFG7/PTC7/Ectodermin functions as a tumor suppressor that promotes development and cellular differentiation…”
Get full text
Journal Article -
8
Tenascin-X: beyond the architectural function
Published in Cell adhesion & migration (01-01-2015)“…Tenascin-X is the largest member of the tenascin (TN) family of evolutionary conserved extracellular matrix glycoproteins, which also comprises TN-C, TN-R and…”
Get full text
Journal Article -
9
A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer
Published in Journal for immunotherapy of cancer (30-01-2024)“…Triple-negative breast cancer (TNBC) prognosis is poor. Immunotherapies to enhance the antibody-induced natural killer (NK) cell antitumor activity are…”
Get full text
Journal Article -
10
Co-Expression of Androgen Receptor and Cathepsin D Defines a Triple-Negative Breast Cancer Subgroup with Poorer Overall Survival
Published in Cancers (15-05-2020)“…In the triple-negative breast cancer (TNBC) group, the luminal androgen receptor subtype is characterized by expression of androgen receptor (AR) and lack of…”
Get full text
Journal Article -
11
Proteolytic control of TGF-β co-receptor activity by BMP-1/tolloid-like proteases revealed by quantitative iTRAQ proteomics
Published in Cellular and molecular life sciences : CMLS (01-03-2015)“…The metalloproteinase BMP-1 (bone morphogenetic protein-1) plays a major role in the control of extracellular matrix (ECM) assembly and growth factor…”
Get full text
Journal Article -
12
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies
Published in Journal for immunotherapy of cancer (04-02-2019)“…Triple-negative breast cancer (TNBC) treatment is currently restricted to chemotherapy. Hence, tumor-specific molecular targets and/or alternative therapeutic…”
Get full text
Journal Article -
13
Acinar-to-Ductal Metaplasia Induced by Transforming Growth Factor Beta Facilitates KRAS G12D -driven Pancreatic Tumorigenesis
Published in Cellular and molecular gastroenterology and hepatology (01-09-2017)“…Transforming growth factor beta (TGFβ) acts either as a tumor suppressor or as an oncogene, depending on the cellular context and time of activation. TGFβ…”
Get full text
Journal Article -
14
Acinar-to-Ductal Metaplasia Induced by Transforming Growth Factor Beta Facilitates KRASG12D -driven Pancreatic Tumorigenesis
Published in Cellular and molecular gastroenterology and hepatology (01-09-2017)“…Background & Aims Transforming growth factor beta (TGFβ) acts either as a tumor suppressor or as an oncogene, depending on the cellular context and time of…”
Get full text
Journal Article -
15
Anti-cathepsin D immunotherapy triggers both innate and adaptive anti-tumour immunity in breast cancer: Antibody-based immunomodulatory therapy of breast cancer
Published in British journal of pharmacology (2023)“…Background and purpose: Triple-negative breast cancer (TNBC) has poorer outcomes than other breast cancer (BC) subtypes, including HER2+ BC. Cathepsin D…”
Get full text
Journal Article -
16
Analysis of Epithelial-Mesenchymal Transition Induced by Transforming Growth Factor β
Published in Methods in molecular biology (Clifton, N.J.) (2016)“…In recent years, the importance of the cell biological process of epithelial-mesenchymal transition (EMT) has been established via an exponentially growing…”
Get more information
Journal Article -
17
Abstract P6-05-11: Prognostic value of androgen receptor and cathepsin D co-expression in non-metastatic triple-negative breast cancer and correlation with other biomarkers
Published in Cancer research (Chicago, Ill.) (15-02-2020)“…Background: Microarrays studies identified the subtype of luminal androgen receptor (LAR) among triple-negative breast cancer (TNBC). This subgroup is distinct…”
Get full text
Journal Article -
18
Latent TGF-β Activation Is a Hallmark of the Tenascin Family
Published in Frontiers in immunology (13-05-2021)“…Transforming growth factor-β (TGF-β) isoforms are secreted as inactive complexes formed through non-covalent interactions between bioactive TGF-β entities and…”
Get full text
Journal Article -
19
Tenascin-X promotes epithelial-to-mesenchymal transition by activating latent TGF-[Beta]
Published in The Journal of cell biology (12-05-2014)“…Transforming growth factor β (TGF-β) isoforms are secreted as inactive complexes formed through noncovalent interactions between the bioactive TGF-β entity and…”
Get full text
Journal Article -
20
TIF1 Suppresses Tumor Progression by Regulating Mitotic Checkpoints and Chromosomal Stability
Published in Cancer research (Chicago, Ill.) (2015)“…The transcription accessory factor TIF1γ/TRIM33/RFG7/PTC7/Ectodermin functions as a tumor suppressor that promotes development and cellular differentiation…”
Get full text
Journal Article